AEMD (Aethlon Medical) Gross Loan

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

AEMD Aethlon Medical Inc AEMD
19 GF Score
Price $6.73
! 2 Warning Signs
View Full Analysis

What is Aethlon Medical Gross Loan?

Gross Loan only applies to banks.

AEMD
19GF Score
Aethlon Medical Inc AEMD
Gross Loan is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aethlon Medical Business Description

Address 11555 Sorrento Valley Road, Suite 203, San Diego, CA, USA, 92121
Aethlon Medical Inc. is a clinical-stage medical device company based in the United States. It is developing the Hemopurifier, an investigational extracorporeal blood-filtration device that uses proprietary lectin-based affinity technology to bind and remove enveloped viruses and extracellular vesicles from biological fluids. The company is pursuing applications in oncology, life-threatening infectious diseases, and organ transplantation, where extracellular vesicles are associated with immune suppression, metastasis, therapy resistance, and disease progression. Aethlon operates as a single reportable business segment and has no approved products or product revenue; it funds operations primarily through equity financings and, historically, government research contracts. Its activities are concentrated in the United States, where it conducts research, development, and clinical testing. The Hemopurifier remains an investigational device limited by law to clinical investigation, and the company's near-term focus is advancing human clinical trials and related regulatory submissions.
19GF Score

Get the complete analysis for AEMD

Gross Loan is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.73
Price